Moderna has sewn up $18 billion in COVID-19 vaccine orders—and it’s negotiating more
Moderna, racing to produce as many COVID-19 vaccine doses as possible this year, says it expects to reap $18.4 billion from its shot this year. Moderna has...
Moderna Therapeutics
Pfizer, Moderna and J&J tout supercharged COVID-19 vaccine output, eyeing nearly 140 million new doses by March
Pfizer, Moderna and Johnson & Johnson execs say they’re working all the angles on increasing COVID-19 vaccine production and expect to amp up weekly deliveries...
Bring on the boosters: Studies show Pfizer, Moderna COVID vaccines are less protective against aggressive variant
In early January, researchers from the University of Texas and Pfizer published a preprint study suggesting that Pfizer’s COVID-19 vaccine could protect against a mutation discovered...
Pfizer, Moderna pledge more mRNA vaccine doses to Europe after AZ supply concerns
After a coronavirus vaccine supply feud between top officials in Europe and COVID-19 vaccine player AstraZeneca, officials there are doubling down on their purchase of an alternative...
Fierce Pharma Asia—Moderna’s new vax plant; Lilly-Junshi COVID-19 cocktail’s emergency nod; AZ’s Hong Kong incubator
Moderna is discussing plans for a new $200 million vaccine production plant with the South Korean government. The FDA granted emergency authorization to Eli Lilly’s...
Moderna sets sights on $200M vaccine factory in Seoul: report
With supply contracts for 50 million COVID-19 vaccine doses in Japan and 40 million in South Korea, Moderna has already made a push into the Asian market....
CDMO Catalent trumpets biologics windfall courtesy of COVID-19
The COVID-19 pandemic has taken a toll on top lines throughout the biopharma industry—but not for New Jersey-based CDMO Catalent, Instead, the pandemic has been a...
First-to-market Pfizer expects a whopping $15B from its COVID-19 shot in 2021
More and more COVID-19 vaccines are nearing the market, but mRNA shots from Pfizer and Moderna are still working off a head start in the...
While Pfizer and Moderna hold the lead, new data from J&J, Novavax show there’s ‘room for everyone’ in the market: analysts
With Novavax and Johnson & Johnson data now in hand, the world has efficacy numbers on at least five COVID-19 vaccine programs. That’s plenty for...
Lonza’s Visp manufacturing lines, tapped in COVID-19 vaccine push, will take time to hit ‘cruising speed’: report
When Moderna first tapped Swiss CDMO juggernaut Lonza to crank out its COVID-19 vaccine, the partners set the goal to eventually hit 600 million to...